These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 29360950

  • 1. Attributable Healthcare Resource Utilization and Costs for Patients With Primary and Recurrent Clostridium difficile Infection in the United States.
    Zhang D, Prabhu VS, Marcella SW.
    Clin Infect Dis; 2018 Apr 17; 66(9):1326-1332. PubMed ID: 29360950
    [Abstract] [Full Text] [Related]

  • 2. Healthcare resource utilization and direct medical costs associated with index and recurrent Clostridioides difficile infection: a real-world data analysis.
    Feuerstadt P, Stong L, Dahdal DN, Sacks N, Lang K, Nelson WW.
    J Med Econ; 2020 Jun 17; 23(6):603-609. PubMed ID: 31999199
    [Abstract] [Full Text] [Related]

  • 3. Healthcare burden of recurrent Clostridioides difficile infection in Japan: A retrospective database study.
    Kunishima H, Ito K, Laurent T, Abe M.
    J Infect Chemother; 2018 Nov 17; 24(11):892-901. PubMed ID: 30190105
    [Abstract] [Full Text] [Related]

  • 4. Health care resource utilization and costs of recurrent Clostridioides difficile infection in the elderly: a real-world claims analysis.
    Nelson WW, Scott TA, Boules M, Teigland C, Parente A, Unni S, Feuerstadt P.
    J Manag Care Spec Pharm; 2021 Jul 17; 27(7):828-838. PubMed ID: 33703939
    [Abstract] [Full Text] [Related]

  • 5. Impact of recurrent Clostridium difficile infection: hospitalization and patient quality of life.
    Wilcox MH, Ahir H, Coia JE, Dodgson A, Hopkins S, Llewelyn MJ, Settle C, Mclain-Smith S, Marcella SW.
    J Antimicrob Chemother; 2017 Sep 01; 72(9):2647-2656. PubMed ID: 28633368
    [Abstract] [Full Text] [Related]

  • 6. Predictors and burden of hospital readmission with recurrent Clostridioides difficile infection: a French nation-wide inception cohort study.
    Dinh A, Le Monnier A, Emery C, Alami S, Torreton É, Duburcq A, Barbier F.
    Eur J Clin Microbiol Infect Dis; 2019 Jul 01; 38(7):1297-1305. PubMed ID: 30941532
    [Abstract] [Full Text] [Related]

  • 7. A Comprehensive Study of Costs Associated With Recurrent Clostridium difficile Infection.
    Rodrigues R, Barber GE, Ananthakrishnan AN.
    Infect Control Hosp Epidemiol; 2017 Feb 01; 38(2):196-202. PubMed ID: 27817758
    [Abstract] [Full Text] [Related]

  • 8. Economic burden of primary compared with recurrent Clostridium difficile infection in hospitalized patients: a prospective cohort study.
    Shah DN, Aitken SL, Barragan LF, Bozorgui S, Goddu S, Navarro ME, Xie Y, DuPont HL, Garey KW.
    J Hosp Infect; 2016 Jul 01; 93(3):286-9. PubMed ID: 27209056
    [Abstract] [Full Text] [Related]

  • 9. Attributable Cost of Clostridium difficile Infection in Pediatric Patients.
    Mehrotra P, Jang J, Gidengil C, Sandora TJ.
    Infect Control Hosp Epidemiol; 2017 Dec 01; 38(12):1472-1477. PubMed ID: 29173236
    [Abstract] [Full Text] [Related]

  • 10. Estimating excess mortality and economic burden of Clostridioides difficile infections and recurrences during 2015-2019: the RECUR Germany study.
    Antunes A, Tricotel A, Wilk A, Dombrowski S, Rinta-Kokko H, Andersson FL, Ghosh S.
    BMC Infect Dis; 2024 May 31; 24(1):548. PubMed ID: 38822244
    [Abstract] [Full Text] [Related]

  • 11. Healthcare resource use and attributable cost of Clostridium difficile infection: a micro-costing analysis comparing first and recurrent episodes.
    Tresman R, Goldenberg SD.
    J Antimicrob Chemother; 2018 Oct 01; 73(10):2851-2855. PubMed ID: 29982502
    [Abstract] [Full Text] [Related]

  • 12. Burden of Clostridium difficile-associated disease among patients residing in nursing homes: a population-based cohort study.
    Yu H, Baser O, Wang L.
    BMC Geriatr; 2016 Nov 25; 16(1):193. PubMed ID: 27884118
    [Abstract] [Full Text] [Related]

  • 13. Attributable costs and length of stay of hospital-acquired Clostridioides difficile: A population-based matched cohort study in Alberta, Canada.
    Leal JR, Conly J, Weaver R, Wick J, Henderson EA, Manns B, Ronksley P.
    Infect Control Hosp Epidemiol; 2019 Oct 25; 40(10):1135-1143. PubMed ID: 31342884
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hospitalization stay and costs attributable to Clostridium difficile infection: a critical review.
    Gabriel L, Beriot-Mathiot A.
    J Hosp Infect; 2014 Sep 25; 88(1):12-21. PubMed ID: 24996516
    [Abstract] [Full Text] [Related]

  • 17. Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach.
    Desai K, Gupta SB, Dubberke ER, Prabhu VS, Browne C, Mast TC.
    BMC Infect Dis; 2016 Jun 18; 16():303. PubMed ID: 27316794
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Economic Impact of Recurrent Clostridioides difficile Infection in the USA: A Systematic Literature Review and Cost Synthesis.
    Reveles KR, Yang M, Garcia-Horton V, Edwards ML, Guo A, Lodise T, Bochan M, Tillotson G, Dubberke ER.
    Adv Ther; 2023 Jul 18; 40(7):3104-3134. PubMed ID: 37210680
    [Abstract] [Full Text] [Related]

  • 20. Recurrent Clostridium difficile infection in intensive care unit patients.
    Jasiak NM, Alaniz C, Rao K, Veltman K, Nagel JL.
    Am J Infect Control; 2016 Jan 01; 44(1):36-40. PubMed ID: 26432184
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.